(Report ID: 180020) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,651 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 50 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 180020 | Aug, 3, 2006 | 77 | Female |
List of drugs the patient takes:
| Drug |
Effexor Xr |
Clarithromycin |
Xanax |
List of drug interactions, adverse side effects / events the patient has:
| Name |
Cardiac Tamponade |
Cerebral Ischaemia |
Condition Aggravated |
Partial Seizures With Secondary Generalisation |
Pericardial Effusion |
Sensation Of Heaviness |
Systemic Sclerosis |
Results from eHealthMe: 50 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Cardiac Tamponade | 1 (2.00%) |
Cerebral Ischaemia | 1 (2.00%) |
Condition Aggravated | 13 (26.00%) |
Partial Seizures With Secondary Generalisation | 1 (2.00%) |
Pericardial Effusion | 1 (2.00%) |
Sensation Of Heaviness | 1 (2.00%) |
Systemic Sclerosis | 1 (2.00%) |
2) Top drug interactions, adverse side effects reported for the past 12 months:
3) Top co-used drugs drugs reported for the past 12 months:
4) Top drug interactions, adverse side effects reported of all time:Death: 7 (14.00% of total reports) Cancer: 0
| Name | Count (% of total reports) |
1 | Drug Dependence | 43 (86.00%) |
2 | Depression | 32 (64.00%) |
3 | Drug Withdrawal Syndrome | 30 (60.00%) |
4 | Drug Ineffective | 30 (60.00%) |
5 | Anxiety | 24 (48.00%) |
6 | Asthenia | 24 (48.00%) |
7 | Dizziness | 23 (46.00%) |
8 | Hypoaesthesia | 21 (42.00%) |
9 | Fatigue | 21 (42.00%) |
10 | Weight Decreased | 20 (40.00%) |
5) Top co-used drugs drugs reported of all time:
| Name | Count |
1 | Biaxin | 50 |
2 | Oxycontin | 42 |
3 | Oxycodone Hcl | 33 |
4 | Soma | 32 |
5 | Ambien | 29 |
6 | Elavil | 25 |
7 | Albuterol | 25 |
8 | Ativan | 25 |
9 | Cephalexin | 24 |
10 | Methadone Hcl | 24 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
Lialda for Crohn's Disease (Nov, 21, 2008)
|
Hydrochlorothiazide (Actavis Elizabet... for Blood Pressure (Nov, 21, 2008)
|
Proscar (Merck) - 5MG for Hair Loss In Men (Nov, 21, 2008)
|
Amiodarone Hydrochloride (Alphapharm)... for Afib (Nov, 21, 2008)
|
Proscar (Merck) - 5MG for Hair Loss In Men (Nov, 21, 2008)
|
Zyrtec (Mcneil Consumer) - 10MG for Allergies (Nov, 21, 2008)
|
Allopurinol (Apotex Inc) - 300MG for Gout - Chronic (Nov, 21, 2008)
|
Nadolol for Anxiety (Nov, 21, 2008)
|
Depakote (Abbott) - EQ 500MG VALPROIC... for Epilepsy (Nov, 21, 2008)
|
Cymbalta (Lilly) - EQ 20MG BASE for Depression (Nov, 21, 2008)
|
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|